Organigram Implements Enhanced Testing Protocol

Organigram Supports Health Canada Auditing Improvements MONCTON, NEW BRUNSWICK–(Marketwired – Feb 9, 2017) – Organigram Holdings Inc. (TSXV: OGI) (OTC: OGRMF) (the “Company” or “Organigram”) is providing this update...
- February 9th, 2017 at 7:46 am

GW Pharma Reports FY17-Q1 Financials

GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational Progress Epidiolex® NDA submission and launch preparation on track New Positive Phase 2 glioma data further demonstrates value...
- February 7th, 2017 at 8:44 am

SXSW Interactive to See a Surge of Cannabis Content

The South by Southwest (SXSW) Conference & Festivals, a major gathering in Austin, TX that will celebrate its 31st anniversary this year, is known for allowing attendees to discover the...
- February 5th, 2017 at 6:01 pm

CanniMed Therapeutics Adds 1658 Patients in Q1

CanniMed Therapeutics Inc. Provides Update on Patient Growth Rates, Sales Volume and Product Supply SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX:CMED) (“CMED” or the “Company”), a leading plant biopharmaceutical company...
- February 3rd, 2017 at 8:14 am

ScottsMiracle-Gro Refines its Cannabis Strategy

ScottsMiracle-Gro (NYSE: SMG) reported its FY17-Q1 results for the quarter ending 12/31/16 on January 31st, with sales of $247mm in what is a seasonally slow quarter rising 27%. Driving the...
- February 1st, 2017 at 1:58 pm

Canopy Growth (TSX: WEED) Closes Mettrum Acquisition

As previously announced, Canopy Growth (TSX: WEED) (OTC: TWMJF) closed its acquisition of Mettrum after the close of business. We are extremely pleased that we have been able to...
- January 31st, 2017 at 6:36 pm